联系

(电子邮件保护)
+1 941 755 6644

遵循

信息

欢迎来到Archer制药公司的网站! 使用这个面板来浏览网站的所有页面.

新闻 & 新葡萄棋牌平台网站
传媒查询,请致电941 755 6644与我们联络.

档案

立即发布
联系人:Kristen Bridges (850) 222-2140
星期二,2008年10月21日

佛罗里达州萨拉索塔. – A team of world-renowned scientists today announced the launch of 新葡萄棋牌平台网站制药公司., a new company that will use modern technologies for the identification of novel treatments for Alzheimer’s disease. 新葡萄棋牌平台网站制药公司.该公司由首席执行官Michael 马伦领导.B.B.S., Ph.D. 首席技术官Fiona 克劳福德博士.D., was created based on the groundbreaking research that their team has been conducting in Florida for the past five years.

新葡萄棋牌平台网站制药公司. has several compounds that are ready to enter clinical development, 包括 ARC029 and ARC031. These compounds have been manufactured at the Sarasota-based facility to U.S. Food and Drug Administration (FDA) regulatory standards (GMP). Both are targeted at the reduction of soluble amyloid proteins in the brain – thought by many to be the main culprits in degeneration of neurons in the brains of Alzheimer’s disease sufferers. 此外,新葡萄棋牌平台网站制药公司 .. 还有其他药物处于临床前阶段吗, 包括 Gamma Secretase Inhibitors and BACE Inhibitors. These approaches are designed to attack the Alzheimer’s disease soluble amyloid in different ways, providing complementary approaches to the lead compounds. ARC029 was selected from approximately 2,000 agents as 新葡萄棋牌平台网站制药公司.’s first-line treatment for Alzheimer’s because it was one of the most proficient at lowering amyloid levels in preclinical models. In these models ARC029 reduces brain amyloid levels by largely unexplored biological mechanisms.

“ARC029 acts to lower the soluble forms of amyloid before they damage the brain’s neurons,”医生说。. 马伦. “我们相信这是可溶的, 而不是沉积的形式, 这种疾病的真正罪魁祸首是什么, 所以减少它们是这个化合物的目标.”

“Alzheimer’s disease is a growing problem around the world, 给病人带来毁灭性的后果, 照顾者和家庭,”医生说。. 克劳福德. “We now have strategies to tackle the cause, not just the consequences, of Alzheimer’s disease. We are confident that the expertise and dedication of the Archer staff will lead to effective treatments for this terrible disease.”

I/IIA期临床试验, 目前正在欧洲进行, 是为了评估尼伐地平的安全性, ARC029的有效成分, 阿尔茨海默病患者. The study has shown that the drug was well tolerated in Alzheimer’s patients. While neither ARC029 nor ARC031 is currently available in the United States (U.S.), Archer制药公司. 预计将继续与美国合作.S. 在接下来的几个月内进行临床研究. 新葡萄棋牌平台网站制药公司. intends to fast track ARC029 and ARC031, while continuing to work on other therapeutic approaches. 新葡萄棋牌平台网站制药公司. is a fully independent health care company dedicated to enhancing and extending healthy human life. For more information or to invest in 新葡萄棋牌平台网站制药公司.,请致电(941)755-6644或访问WWW.ArcherPharma.com.

本新闻稿中包含的所有声明, and oral statements that may be made by the Company or any of its officers, 董事, employees or representatives acting on the Company’s behalf, 这不是对历史事实的陈述, 包括, 但不限于, the projected financial information contained in this Memorandum, statements regarding the Company’s current business strategy, 未来的业务, 技术能力, 融资需求, 金融资源, 定价, 市场, 财务状况, 预估收入, 预计成本, 前景, 管理的计划和目标, as well as information concerning expected actions of third parties, 比如供应商, and expected characteristics of competing products are based upon current expectations and constitute “forward looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995 and, 像这样, 只说到约定的日期. Such forward looking statements involve known and unknown risks, uncertainties and other factors that could cause the actual results to be materially different from historical results or from any future results expressed or implied by such forward looking statements. The Company wishes to caution readers not to place undue reliance on any forward looking statements. The Company has disclosed important factors that could cause the actual results to differ materially from expectations (“cautionary statements”) under the heading “Risk Factors” and elsewhere in this Memorandum. The cautionary statements qualify all forward looking statements attributable to the Company or persons acting on the Company’s behalf. In addition to statements that explicitly describe such risks and uncertainties, readers are urged to consider statements that include the terms “believe,”“信念,”“希望,”“计划,”“预测,”“意愿,”“估计,” “project” or the like to be uncertain and forward looking. The Company does not have any obligation to update or revise publicly any forward looking statements, 是否是新信息的结果, 未来事件或其他. Although the Company believes that the expectations underlying the forward looking statements are reasonable, it cannot assure that such expectations will prove to be correct.